Andrzej Horban

Telaprevir for Retreatment of HCV Infection

Stefan Zeuzem, Pietro Andreoné, Stanislas Pol et al. · New England Journal of Medicine · 2011 · 1.5K citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Maraviroc for Previously Treated Patients with R5 HIV-1 Infection

Roy M. Gulick, Jacob Lalezari, James Goodrich et al. · New England Journal of Medicine · 2008 · 741 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study

Frank van Leth, Praphan Phanuphak, Kiat Ruxrungtham et al. · The Lancet · 2004 · 683 citations

Pharmacy, Pharmacology, Pharmacotherapy +12

Prevalence of Drug‐Resistant HIV‐1 Variants in Untreated Individuals in Europe: Implications for Clinical Management

Annemarie M. J. Wensing, David van de Vijver, Gioacchino Angarano et al. · The Journal of Infectious Diseases · 2005 · 420 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Influence of Hepatitis C Virus Infection on HIV‐1 Disease Progression and Response to Highly Active Antiretroviral Therapy

Jürgen K. Rockstroh, Amanda Mocroft, Vincent Soriano et al. · The Journal of Infectious Diseases · 2005 · 385 citations

Life Sciences, Immunology, Infectious Diseases +17